Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis
The Journal of International Advanced Otology · 2024
DOI: 10.5152/iao.2024.231374 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of International Advanced Otology, 2024. Verfasst von Do Hyeon Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea. Hauptthemen laut MEDLINE: Biological Therapy, Eosinophilia, Otitis Media. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Eosinophilic otitis media, first reported in Japan, is a viscous, intractable otitis media often linked to bronchial asthma and chronic rhinosinusitis, characterized by highly viscous middle ear effusion. Its pathological mechanism remains unclear and the condition occasionally does not respond to steroids. It is now recognized as a rare type 2 inflammatory disease and should be treated specifically to enhance quality of life. This systematic review and meta-analysis evaluated the efficacies of biologic treatments.
Methods
We searched PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases up to September 2023. We retrieved ear examination findings, otitis media-related and symptom scores, air–bone gaps and hearing thresholds, serum eosinophil, and immunoglobulin E (IgE) levels before and after biologic treatments.
Results
Biologics treatment significantly improved subjective otitis media-related scores, compared with control group (standard mean difference (SMD) −1.62; 95% confidence interval (CI) [−2.24; −1.01], I2=54%). Additionally, the serum eosinophil counts and IgE levels significantly decreased (SMD −1.40; 95% CI [−1.99; −0.81], I 2=0%) after 6-12 months of biologic treatments, but the hearing thresholds did not significantly change. There were no significant differences between groups treated with dupilumab and groups treated with other biologics.
Conclusion
Biologics treatment for eosinophilic otitis media significantly improved subjective otitis media-related scores and decreased serum eosinophil and IgE levels, but no significant changes in hearing threshold. More randomized cohort studies are needed to confirm the efficacies of biologics in patients with refractory eosinophilic otitis media. Cite this article as: Kim DH, Park KH, Kang YJ. Efficacy of biologic therapies for eosinophilic otitis media: A systematic review and meta-analysis. J Int Adv Otol. 2024;20(4):331-338.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea.
Zitieren
APA
Kim, D. H., Hoon Park, K., & Jin Kang, Y. (2024). Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis. The Journal of International Advanced Otology. https://doi.org/10.5152/iao.2024.231374
Vancouver
Kim DH, Hoon Park K, Jin Kang Y. Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis. The Journal of International Advanced Otology. 2024. doi:10.5152/iao.2024.231374
BibTeX
@article{Kim2024,
author = {Kim, Do Hyeon and Hoon Park, Kye and Jin Kang, Yun},
title = {Efficacy of Biologic Therapies for Eosinophilic Otitis Media: A Systematic Review and Meta-analysis},
journal = {The Journal of International Advanced Otology},
year = {2024},
doi = {10.5152/iao.2024.231374}
}
EUVIMED